August 2011

M3 USA, a group company of M3, Inc., a global leader in healthcare marketing, clinical trials, market research and physician recruitment services, has acquired, the largest physician network in the United Kingdom.

  • has more than 184,000 members and is the most popular professional resource for physicians in the United Kingdom
  • The demand for pharmaceutical digital marketing services in the UK market is expected to grow rapidly in the coming years
  • The acquisition follows on the heels of M3’s November 2010 purchase of London-based EMS Research

About M3 USA

M3 USA is a subsidiary of M3, Inc., a publicly traded company in the Tokyo Stock Exchange with subsidiaries in major markets including USA, France, UK, Japan, South Korea, and China. M3 was founded in 2000 with the goal of changing the world of medicine through full use of the power of the internet. M3 USA Group provides services to the healthcare and life sciences industry, including market research, medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services.

About has a membership of over 184,000 doctors, with 97 per cent saying that the network is their most trusted source of information. It is the online resource most frequently used by them and provides forums for discussion, education and extensive editorial content, including conference highlights to support them in making the best decisions for the care of their patients. The network was created for doctors, by doctors in 1998. More than 300 doctors now act as advisers and clinical information contributors. Credibility and integrity of all published materials is assured thanks to an experienced editorial team and a code of absolute transparency for all information published.

Acquisition of

Client Highlights

Transaction Details

“The addition of is a powerful expansion of our commitment to providing the pharmaceutical industry full global access. Concurrent with our investment in the growth of to service the US pharmaceutical market, this acquisition allows us to dramatically extend our services to physicians and pharmaceutical companies into the UK.”
Aki Tomaru, CEO, M3 USA

Get in touch with us

Contact Us

  • Hidden
  • This field is for validation purposes and should be left unchanged.